For the quarter ending 2026-03-31, MANE has $397,356K in assets. $6,716K in debts. $168,412K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 168,412 | 21,766 | ||
| Marketable securities at fair value | 222,385 | 120,096 | ||
| Prepaid expenses and other current assets | 6,272 | 10,632 | ||
| Total current assets | 397,069 | 152,494 | ||
| Property, plant and equipment, net | 21 | 22 | ||
| Right-of-use asset and other long-term assets | 266 | 103 | ||
| Total non-current assets | 287 | 125 | ||
| Total assets | 397,356 | 152,619 | ||
| Accounts payable | 1,071 | 2,126 | ||
| Accrued expenses | 5,606 | 6,979 | ||
| Other current liabilities and lease liabilities | 39 | 47 | ||
| Total current liabilities | 6,716 | 9,152 | ||
| Lease liabilities - non-current | 0 | 4 | ||
| Total liabilities | 6,716 | 9,156 | ||
| Redeemable convertible preferred stock-Series APreferred Stock | 0 | 36,860 | ||
| Redeemable convertible preferred stock-Series BPreferred Stock | 0 | 78,903 | ||
| Redeemable convertible preferred stock-Series CPreferred Stock | 0 | 150,563 | ||
| Subscription receivable | 0 | 1,849 | ||
| Common stock, 0.00001 par value, 200,000,000 and 267,466,797 shares authorized as of march31, 2026 and december31, 2025, respectively and 37,340,290 and 749,760 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 1 | 1 | ||
| Additional paid-in capital | 543,044 | 2,346 | ||
| Subscription receivable | 1,228 | - | ||
| Accumulated other comprehensive income | -524 | 60 | ||
| Accumulated deficit | -150,653 | -123,421 | ||
| Total stockholders equity (deficit) | 390,640 | -121,014 | ||
| Total liabilities, redeemable convertible preferred stock, and stockholders equity (deficit) | 397,356 | 152,619 | ||
Veradermics, Inc (MANE)
Veradermics, Inc (MANE)